| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Maxaquin | Macs Pharmaceuticals | Mac?s Pharmaceuticals Ltd | 4% | 30ml | Injection | per vial | KES 30.00 |
| Bioquin | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 80mg | 60ml | Syrup | per 5ML | KES 35.00 |
| Bioquin | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 80mg | 1000 | Tablet | per tablet | KES 700.00 |
| Chloroquin | Laborate | Harley's Limited | 64.50mg | 30ml | Injection | per vial | KES 18.00 |
| Chloroquine | Dawa Limited | Dawa Limited | 250mg | 1000 | Tablet | per tablet | KES 490.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 60ml | Syrup | per 5ML | KES 45.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 100ml | Syrup | per 5ML | KES 64.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 5litres | Syrup | per 5ML | KES 1023.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 100 | Tablet | per tablet | KES 240.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 1000 | Tablet | per tablet | KES 1,045.00 |
| Intaclor | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 80mg | 1000 | Tablet | per tablet | KES 836.00 |
| Fitoquine | Dawa Limited | Dawa Limited | 40mg | 30ml | Injection | per vial | KES 25.00 |
| Oroquin | Medipharm Sales Ltd | Kulal International Ltd. | 75mg | 60ml | Syrup | per 5ML | KES 400.00 |
| Phinaquin | Sphinx Pharmaceuticals Ltd | Omaera Pharmaceuticals Ltd | 50mg | 60ml | Syrup | per 5ML | KES 18.00 |
| Phinaquin | Sphinx Pharmaceuticals Ltd | Omaera Pharmaceuticals Ltd | 50mg | 500ml | Syrup | per 5ML | KES 32.00 |
| Phinaquin | Sphinx Pharmaceuticals Ltd | Omaera Pharmaceuticals Ltd | 50mg | 1 litre | Syrup | per 5ML | KES 60.00 |
| Phinaquin | Sphinx Pharmaceuticals Ltd | Omaera Pharmaceuticals Ltd | 50mg | 5litres | Syrup | per 5ML | KES 260.00 |
| Chloroquine phosphate More info | |
|---|---|
| Mode Of Action | May inhibit meroThey are also thought to inhibit heme polymerase activity resulting in accumulation of free heme, which is toxic to the parasites. |
| Drug Indication | amoeba in the liver (used mostly after the failure of metronidazole). Indications: Malarial treatment and prophylaxis where chloroquine resistant is not encountered, rheumatic arthritis, discoid erythematosus. |
| Precautions | Hepatic disorders, alcohol, renal insufficiency, hepatotoxic drugs, history of myasthenia gravis, avoid operation of machinery, regular eye inspections on prolonged use, psoriasis. |
| Contra-Indications | Severe GI, neurological and blood disorders, pregnancy, hepatotoxic drugs, epilepsy, general psoriasis. |
| Side Effects | GI disturbances, skin eruptions, pru-ritis, headache, visual disturbances, hearing disorders, mental changes, blood dyscra-sias, hair loss, hair pigment bleach, blue-black pigmentation mucus membrane and skin, photosensitivity, tinnitus, myopathy, neuropathy, hypotension. ECG changes. |
| Dosage | Prophylaxis - 500mg weekly from one week before
exposure. Continue for 4 weeks after exposure.
Acute attacks: Initially 4 tablets, then 2 six hours later then 2 OD x 3/7. Children: Initial dose; 10mg/kg (of Base) then 5mg/kg after 6hours then 50mg/kg OD x 3/7. |
| Pregnancy Category | Category D |
| Pregnancy Category Description | Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Anti-Malarials |